Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Janssen
Company Monitoring Page for Janssen
job ratings for Janssen
12/12/21
industry:
Pharma -Research
job title:
monitor
company:
Janssen
job rating:
2
Fear based management is not becoming of them
latest headlines for company on cafepharma
ESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPC
Clinical Trials Arena
Tue, 09/17/24 - 11:13 am
Tags:
Eli Lilly
,
ESMO
,
lutetium zadavotide guraxetan
,
Astellas
,
Janssen
,
metastatic castration-resistant prostate cancer
Evernorth Will Offer a Private-Label Stelara Biosimilar in 2025
Managed Healthcare Executive
Thu, 09/5/24 - 10:32 pm
Tags:
Evernorth Health
,
Stelara
,
biosimilars
,
Janssen
,
JNJ
J&J drops Addex-partnered epilepsy drug after reviewing failed phase 2 trial data
Fierce Biotech
Thu, 07/18/24 - 11:20 am
Tags:
JNJ
,
Addex Therapeutics
,
epilepsy
,
ADX71149
,
Janssen
J&J to seek appeal of $150M verdict in long-spanning HIV meds off-label marketing case
Fierce Pharma
Mon, 06/17/24 - 10:31 pm
Tags:
JNJ
,
Janssen
,
off-label
,
HIV
,
legal
,
whistleblower lawsuits
,
Prezista
,
Intelence
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
Tags:
oncology
,
cancer
,
Keytruda
,
Revlimid
,
Opdivo
,
Imbruvica
,
Darzalex
,
Merck
,
Bristol Myers Squibb
,
AbbVie
,
Janssen
Janssen’s antibody drug shows phase 2 potential in rheumatoid arthritis
Biopharma Reporter
Thu, 11/9/23 - 09:55 am
Tags:
Janssen
,
JNJ
,
rheumatoid arthritis
,
nipocalimab
,
clinical trials
J&J books manufacturing space at Fujifilm Diosynth's upcoming mega-plant in North Carolina
Fierce Pharma
Wed, 11/8/23 - 09:57 pm
Tags:
JNJ
,
Janssen
,
Fujifilm Diosynth Biotechnologies
,
CDMOs
,
North Carolina
GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy
Reuters
Tue, 10/31/23 - 10:18 am
Tags:
GSK
,
JNJ
,
hepatitis B
,
JNJ-3989
,
Janssen
Janssen reports data from Phase III trial of lung cancer drug
Clinical Trials Arena
Tue, 10/24/23 - 10:21 am
Tags:
JNJ
,
Janssen
,
Rybrevant
,
clinical trials
,
non-small cell lung cancer
Janssen tackles racial gap in Phase IIIb psoriasis trial with Tremfya
Clinical Trials Arena
Fri, 10/20/23 - 11:39 am
Tags:
Janssen
,
psoriasis
,
Tremfya
,
clinical trials
Janssen’s Tremfya maintains three years of remission in Phase II Crohn’s disease trial
Clinical Trials Arena
Tue, 10/17/23 - 11:45 am
Tags:
JNJ
,
Janssen
,
clinical trials
,
Crohn's Disease
,
Tremfya
Janssen and Atropos partner to expedite clinical development
Clinical Trials Arena
Thu, 09/28/23 - 10:10 am
Tags:
JNJ
,
Janssen
,
Atropos Health
,
real world data
After Kenvue spinoff, J&J says it's 'uniting' Janssen and medtech segments under one brand
Fierce Pharma
Thu, 09/14/23 - 11:13 pm
Tags:
JNJ
,
Janssen
,
Medtech
,
rebranding
J&J's patient assistance program suffers data breach, IBM says
Fierce Pharma
Thu, 09/7/23 - 09:43 am
Tags:
JNJ
,
Janssen
,
IBM
,
patient assistance programs
,
cybersecurity
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
Tags:
FDA
,
Sandoz
,
Novartis
,
Gilead Sciences
,
Pfizer
,
Neurocrine
,
Regeneron
,
Ipsen
,
Revance Therapeutics
,
Delcath Systems
,
Janssen
,
Galera Therapeutics
,
Biogen
,
Roche
,
Mesoblast
,
Taiho Oncology
Janssen granted additional European Commission approval for bispecific antibody
Biopharma Reporter
Tue, 08/22/23 - 09:54 am
Tags:
Janssen
,
JNJ
,
bispecific antibodies
,
Europe
,
relapsed or refractory multiple myeloma
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
Tags:
CMS
,
Medicare
,
drug pricing
,
Bristol Myers Squibb
,
Janssen
,
Merck
,
Pfizer
,
Amgen
,
Boehringer Ingelheim
,
Pharmacyclics
,
AstraZeneca
,
Astellas
,
GSK
Janssen’s newly-merged infectious disease and vaccine unit sees significant pipeline cuts
Fierce Biotech
Thu, 07/20/23 - 10:18 am
Tags:
JNJ
,
Janssen
,
infectious disease
,
vaccines
,
hepatitis
,
HIV
Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
Medical Marketing and Media
Tue, 07/11/23 - 11:27 pm
Tags:
JNJ
,
Janssen
,
Nanobiotix
,
NBTXR3
,
soft tissue sarcoma
,
Hensify
Janssen’s trial of plaque psoriasis therapy meets endpoints
Clinical Trials Arena
Wed, 07/5/23 - 10:18 am
Tags:
Janssen
,
JNJ
,
clinical trials
,
JNJ-2113
,
plaque psoriasis
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.